• Chemistry of Silybin: Structure, Methods, and Research Value

  2026-08-22

  The review by Křen and colleagues organizes more than five decades of silybin chemistry, linking its flavonolignan structure to stereochemical assignment, diastereomer separation, synthesis, derivatization, and antioxidant behavior. Its main practical contribution is a chemical framework for distinguishing purified silybin species from the broader silymarin mixture when designing mechanistic or translational experiments.

• UTP Solution for Precision RNA Workflows

  2026-08-22

  UTP Solution (100 mM) supports controlled in vitro transcription, RNA amplification, and siRNA production without introducing nuclease contamination into sensitive assays. This guide connects practical nucleotide handling with the TRIM66 olfactory-receptor study, showing how reproducible RNA workflows can strengthen epigenetic and neural gene-expression research.

• GS-441524 Prodrug Research Workflows

  2026-08-21

  Build more reliable GS-441524 antiviral and conversion studies by combining controlled solubilization, matrix-specific incubation, and LC–MS/MS measurement. This workflow distinguishes parent-compound exposure from metabolite formation, supporting sharper antiviral screening and pharmacokinetic interpretation.

• AO/PI Double Staining Kit for Organoid Viability

  2026-08-20

  The AO/PI Double Staining Kit converts a rapid fluorescent readout into a practical map of viable, apoptotic, and necrotic cell states. Its single-assay format is especially useful for patient-derived glioma organoids, where drug response can be compared across intact microenvironment-preserving models and dissociated cell suspensions.

• HyperScript First-Strand cDNA Synthesis Kit for qPCR

  2026-08-20

  The HyperScript First-Strand cDNA Synthesis Kit supports RNA template reverse transcription when transcript abundance, length, or secondary structure complicates gene-expression assays. This article translates lessons from a colorectal cancer chemosensitization study into practical decisions for cDNA preparation, qPCR interpretation, and experimental controls.

• I-BET151 (GSK1210151A): Research Guide

  2026-08-19

  I-BET151, also called GSK1210151A, is a selective BET bromodomain inhibitor for mechanistic cancer biology research. It targets BRD2, BRD3, and BRD4, and supports studies of transcriptional regulation, apoptosis, and cell cycle arrest in models including MLL-fusion leukemia.

• AO/PI Double Staining Kit: 5 Lab Scenarios

  2026-08-19

  This scenario-driven guide explains how the AO/PI Double Staining Kit, SKU K2238, can support practical cell viability, apoptosis detection, and necrosis detection workflows. It connects dual-dye interpretation with sample compatibility, handling, quantitative reporting, and evidence-based vendor selection.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-18

  Oh et al. establish a scalable human model in which hiPSCs are rapidly differentiated into functional sensory neurons and infected with HSV-1 under latent conditions. The model reproduces multiple hallmarks of neuronal latency, including the absence of infectious virus, reduced lytic transcription, latency-associated transcript expression, viral heterochromatin, and reactivation after forskolin or PI3K inhibition.

• MCC950 sodium: NLRP3 Workflow Guide

  2026-08-18

  MCC950 sodium, also known as CRID3 sodium salt, provides a selective way to test whether NLRP3 drives cytokine release and pyroptosis rather than relying on broad anti-inflammatory effects. This guide translates its use from oxidative-stress endothelial assays to macrophage, PBMC, endotoxemia, and autoimmune disease workflows, with practical controls and troubleshooting.

• GntR Phosphorylation in Streptococcus suis Virulence

  2026-08-17

  The reference study identifies a phosphorylation-dependent switch in which the Streptococcus suis serotype 2 kinase STK modifies the GntR transcription factor at Ser-41, suppressing nox transcription and weakening oxidative-stress resistance. Its integrated genetic, biochemical, transcriptional, redox, and infection models connect a specific phosphorylation event to NADH accumulation and reduced virulence, providing a useful framework for protein phosphorylation signaling research.

• Live-Dead Bacterial Staining Kit: Viability Guide

  2026-08-17

  The Live-Dead Bacterial Staining Kit uses NucGreen dye and EthD-III to distinguish bacteria with intact membranes from bacteria with compromised membranes. This dual-fluorescence bacterial viability assay supports research measurement of bacterial live-dead differentiation, but it does not replace culture, molecular identification, or clinical diagnosis.

• Exosomal Egr2, RNF8/DAPK1, and Ischemic Stroke

  2026-08-16

  The reference study identifies a mechanistic pathway in which Egr2 carried by bone marrow mesenchymal stem cell exosomes protects OGD/R-injured neuronal cells through transcriptional activation of RNF8 and suppression of DAPK1. Its layered use of exosome characterization, promoter assays, rescue experiments, and Co-IP provides a useful framework for evaluating protein and regulatory networks, although validation remains limited to an in vitro neuronal injury model.

• Anti-Diabetic Drugs and Fracture Risk

  2026-08-15

  This systematic review and network meta-analysis integrates randomized evidence to compare fracture outcomes across anti-diabetic drug classes and individual agents in type 2 diabetes. Its main practical contribution is a more comparative safety framework: trelagliptin showed a statistically significant increase in fracture risk, whereas voglibose and albiglutide showed lower risk, while most other agents—including ertugliflozin—did not differ significantly from comparators.

• Ivermectin Workflows for Parasitology Research

  2026-08-14

  Ivermectin is a broad-spectrum anti-parasitic research compound suited to controlled dose-response, motility, viability, and host-cell selectivity workflows. This guide combines practical formulation advice with assay-design lessons from a Gasdermin C study while clearly separating established parasitology applications from exploratory cancer biology.

• Cryo-EM Reveals HCAR3 Agonist Selectivity

  2026-08-14

  Ye et al. used cryo-EM structures and cellular cAMP assays to define how HCAR3 recognizes several agonists and how its binding pocket differs from HCAR2. The study provides a structural framework for interpreting receptor selectivity and guiding lipid metabolism regulation research without relying solely on HCAR2-associated pharmacology.

11520 records 1/768 page Next 12345 下5页 Last page